Study to Find Hidden Heart Failure in At-Risk Adults Aged 40 to 69 in German Cities Using Mobile MRI Screening
Led by German Heart Institute · Updated on 2026-04-01
600
Participants Needed
1
Research Sites
521 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating the prevalence of unrecognized heart failure in adults aged 40 to 69 years who have risk factors but show no symptoms. This observational study focuses on urban populations in large German cities with over 1 million residents, aiming to improve early detection of heart failure and provide a modern screening approach tailored to at-risk patients. The study also compares its findings with a previous trial conducted in rural areas to better understand differences in heart failure prevalence.
The study uses a mobile, telemedicine-monitored screening method that includes a non-invasive cardiac magnetic resonance imaging CMR examination without needles, stress, or contrast agents. Participants undergo laboratory tests and quality of life assessments in specially equipped mobile MRI units stationed in major cities. Medical staff operate the mobile units under telemedical supervision, and participant consent is obtained remotely via video calls.
Participants will complete questionnaires, blood tests, and the CMR exam at the mobile units. Researchers will track the prevalence of asymptomatic pre-heart failure and chronic kidney disease, as well as adherence to therapy over several years. The study will monitor participants health status at baseline and follow-up points through questionnaires and laboratory data, with the entire participation process occurring in community-based settings to ensure convenience and safety.
CONDITIONS
Brief Title
Determination of the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using CMR
Research Team
P
Prof. Dr. Sebastian Kelle
D
Dr. Gisela Thiede
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Asymptomatic individuals with at least one of the following: diabetes, chronic kidney disease, hypertension, high cholesterol, obesity (BMI > 30), or smoking history
Male, female, or diverse gender
Ability to provide informed consent
Signed informed consent form
You will not qualify if you...
Unable to provide written informed consent
Diagnosed heart failure or prior reduced heart function
Standard MRI contraindications such as pacemaker, defibrillator, intracranial aneurysm clips, or metal in the eyes
Other MRI exclusions as determined by the MRI facility
Participants are screened for eligibility to participate in the trial.
Diagnostic Evaluation
Duration - Single visit
Participants undergo a standardized, non-invasive cardiac magnetic resonance (CMR) imaging exam along with questionnaire-based medical history and laboratory testing using telemedically-supervised mobile diagnostic units.
1 visit (in-person)
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Phase 1 Study to Evaluate Safety and Biomarkers of VS-041 in Adults 50 and Older with Heart Failure with Preserved Ejection Fraction HFpEF
A Phase II Study to Test the Safety and Effectiveness of IBI362 in Adults With Heart Failure and Obesity
AI-Enhanced Continuous Remote Monitoring Using Wearable Devices to Improve Outcomes in Adults with Chronic Heart Failure
Study of Pregnancy History and Circulating Biomarkers in Women Aged 60-74 With Heart Failure and Preserved Ejection Fraction
Study of Characteristics and Types of Heart Failure With Preserved Ejection Fraction HFpEF at Manchester University NHS Foundation Trust
Preventing Kidney Injury in Adults with Acute Heart Failure and Kidney Problems
Comparing Saline Hydration and Furosemide Decongestion Strategies
Screening Study for Heart Failure With Preserved Ejection Fraction in Adults Aged 50 to 89 in the Capital Region of Denmark
Evaluating the Effect of Coronary Artery Stents on Quality of Life in Heart Failure With Preserved Ejection Fraction and Coronary Artery Disease
Study to Find Hidden Heart Failure in At-Risk Adults Aged 40 to 69 in German Cities Using Mobile MRI Screening
Study of Personalized Dual Chamber Cardiac Pacing for Treating Heart Failure With Preserved Ejection Fraction in Adults 40 and Older
Heart Failure With Preserved Ejection Fraction (HFpEF)
Actively Recruiting
50 locations
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Echocardiographic Features Beyond Ejection Fraction and Associated Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
Anthony E Peters, Robert M Clare, Karen Chiswell...
Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.